Valuation: Isodiol International Inc

Market Cap 3.91M 2.74M 2.45M 2.29M 2.08M 265M 3.94M 27.48M 10.73M 135M 10.3M 10.07M 434M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.4M 5.72M 5.34M 4.85M 620M 9.2M 64.16M 25.07M 315M 24.04M 23.52M 1.01B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
Manager TitleAgeSince
Chief Executive Officer - 2017-05-23
Corporate Officer/Principal - 2018-08-29
Director TitleAgeSince
Director/Board Member - 2017-05-23
Director/Board Member - 2018-08-29
Director/Board Member - 2018-11-20
Change 5-day change 1-year change 3-year change Capi.($)
-90.63%+880.01% - - 128
+3.28%+3.41%+41.83%+109.26% 1,032B
+1.83%-1.91%+37.48%+63.80% 614B
+2.44%+4.26%+17.16%+82.94% 471B
+0.65%-1.80%+62.87%+36.55% 350B
+2.92%+3.12%+24.78%+43.51% 337B
+2.42%+0.05%+14.13%+36.19% 268B
+1.86%-0.81%-4.69%+12.20% 246B
+2.42%-2.10%+39.62%+51.96% 218B
+2.17%-1.04%+26.31%+96.51% 179B
Average -7.27%-3.39%+28.83%+59.21% 412.76B
Weighted average by Cap. +2.24%-3.18%+32.46%+69.91%

Financials

2018 2019
Net sales 19.14M 13.42M 11.99M 11.19M 10.16M 1.3B 19.28M 134M 52.52M 660M 50.38M 49.29M 2.12B 22.25M 15.6M 13.94M 13.01M 11.81M 1.51B 22.41M 156M 61.06M 768M 58.57M 57.3M 2.47B
Net income -36.02M -25.26M -22.57M -21.06M -19.13M -2.44B -36.29M -253M -98.85M -1.24B -94.83M -92.78M -3.99B -126M -88.29M -78.89M -73.6M -66.86M -8.54B -127M -884M -346M -4.34B -331M -324M -13.96B
Net Debt -15.55M -10.9M -9.74M -9.09M -8.26M -1.05B -15.67M -109M -42.67M -536M -40.94M -40.05M -1.72B 5.22M 3.66M 3.27M 3.05M 2.77M 354M 5.26M 36.68M 14.33M 180M 13.75M 13.45M 579M
Logo Isodiol International Inc
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-